Conversion therapy using transarterial chemoembolization plus tislelizumab for unresectable hepatocellular carcinoma: effects on tumor necrosis and anti-tumor immune response. - Yao Q; Chen G; Yu Y; Chen Z; An X; Xie X; Wang Q; Chen D; Sun H (Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026)